Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT03182244. IPD Sharing: YES. Countries: 5. Publications: 1.
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02152956. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
ClinicalTrials.gov study NCT01929408. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02545283. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00486265. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
ClinicalTrials.gov study NCT03466294. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
ClinicalTrials.gov study NCT00788892. IPD Sharing: Not stated. Countries: 2. Publications: 1.
AC220 for Children With Relapsed/Refractory ALL or AML
ClinicalTrials.gov study NCT01411267. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy
ClinicalTrials.gov study NCT01170598. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
ClinicalTrials.gov study NCT01025154. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
ClinicalTrials.gov study NCT00085709. IPD Sharing: Not stated. Countries: 3. Publications: 5.
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01266083. IPD Sharing: NO. Countries: 1. Publications: 1.
Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
ClinicalTrials.gov study NCT03709576. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML
ClinicalTrials.gov study NCT00895934. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01912274. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
ClinicalTrials.gov study NCT00867308. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
ClinicalTrials.gov study NCT01656252. IPD Sharing: NO. Countries: 1. Publications: 5.
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
ClinicalTrials.gov study NCT04079738. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older
ClinicalTrials.gov study NCT01814826. IPD Sharing: YES. Countries: 1. Publications: 2.
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
ClinicalTrials.gov study NCT02560025. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.